Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-21

FDA Approved: MONTELUKAST — Supplemental Application (XLCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Montelukast from XLCare Pharmaceuticals Inc., authorizing a supplemental action related to a generic Montelukast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Montelukast (Montelukast)

Snippet

SUPPL AP for MONTELUKAST (MONTELUKAST)